BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
286 hedge funds and large institutions have $6.12B invested in Blueprint Medicines in 2021 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 99 increasing their positions, 94 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 279 → 286 (+7)
1.59% more ownership
Funds ownership: 100.23% → 101.82% (+1.6%)
5% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 94
Holders
286
Holding in Top 10
8
Calls
$36.7M
Puts
$18.9M
Top Buyers
| 1 | +$122M | |
| 2 | +$70M | |
| 3 | +$43.7M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$39.8M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$32.5M |
Top Sellers
| 1 | -$107M | |
| 2 | -$55.9M | |
| 3 | -$53.6M | |
| 4 |
Morgan Stanley
New York
|
-$41.2M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$27.7M |